← Every applicant
Riconpharma LLC FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TOPIRAMATENew drugMay 26, 2026CAPSULE, EXTENDED RELEASE, ORAL |
| SIPONIMODNew drugApr 22, 2025TABLET, ORAL |
| COLESTIPOL HYDROCHLORIDENew drugDec 3, 2024TABLET, ORAL |
| OXCARBAZEPINENew drugNov 22, 2024TABLET, EXTENDED RELEASE, ORAL |
| FLUNISOLIDENew drugJun 16, 2022SPRAY, METERED, NASAL |